Mental health

  • DATABASE (144)

  • ARTICLES (198)

    • DATABASE (144)
    • ARTICLES (198)
  • Sort by
    • Relevance
    • Date

DycodeX brings broad experience in IoT to the farm with advanced cattle tracking and monitoring devices.

AI- and NLP-powered software accelerating clinical research by structuring relevant patient big data and facilitating clinical data searches, with dramatic improvements of up to 90%.

Cobee automates and extends flexibility in compensation and benefits management to meal vouchers, childcare, healthcare, etc., helping firms increase their average employee benefits uptake fourfold.   

As a graduate in Biomedical Engineering from Southeast University as well as Clinical Medicine from Nanjing Medical University, Chai Xueting has always been aware of the issues plaguing the traditional medical imaging system. The exorbitant cost of archiving past records and the lack of a comprehensive medical image sharing system between hospitals for a fully effective diagnosis have long raised concerns in his mind.  But it was while taking his young daughter to the hospital for a health checkup, personally experiencing these issues, that Chai became ever more determined to build a cloud-based medical system – hence his founding of Eimageglobal.  In 2017, Chai won the “Young Tech Giant” Award by Zhejiang Entrepreneur Committee. 

Patrão is a Portuguese co-founder at UpHill whose SaaS helps healthcare professionals keep up-to-speed on the latest clinical treatments and protocols using AI. Despite being heavily involved in the development of the software Simulate, Patrão continues to work in the medical field full-time.He has spent the last decade working at Viseu’s Tondela Hospital Center in the intensive care unit as a physician. He also lectures part-time at his former university Beira Interior, where UpHill was established, and is a researcher for the RISRECP,  the Colombia-based Iberian Network of Researchers in Renal Health and Common Chronic Illnesses.The co-founder also helps produce clinical simulations for producer Hands on Education and holds a doctorate in Medicine from Beira Interior University.

Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.

Founded in 2009, Finnish VC Lifeline Ventures has invested in over 100 early-stage startups, with investments ranging from €100,000 to €2m. Focusing mainly on local tech startups, the VC has 71 tech and non-tech companies in its portfolio.Recent investments in April 2021 include the $100m Series C round of Finnish wellness ring and app Oura Health and the $6.2m seed round of Finnish cleantech Carbo Culture. One of Lifeline’s VC partners, Timo Ahopelto, is an advisor at student-led VC Wave Ventures that also participated in the investment round of Carbo Culture.

After disrupting Portugal’s public healthcare system with video consultations via app, Knokcare is offering its SaaS services to health insurers in Europe and beyond.

A plug&play digital health SaaS that connects remotely to medical devices, patients’ smartphones and sensors, which grew HumanITcare’s client base sixfold during Covid-19.

Gabriel de Maeztu is CTO and co-founder of IOMED Medical Solutions, which facilitates data extraction from electronic health records (EHR) and where he has worked since 2016. He had the idea for the software in 2014 and worked on it from then, completing two internships during that time: at QMENTA, formerly Mint Labs, a US drug development startup dedicated to brain diseases (where he worked in data science) and at Barcelona bioresearch center IDIBAPS in neuro-imaging research.De Maeztu holds a doctorate in Medicine from the International University of Catalonia, where he first had the idea for IOMED. He also holds a bachelor’s in Mathematics and a postgraduate qualification in Data Processing, Data Science and Big Data. He was also previously a developer at Barcelona tech agency Chroma Branding. 

Alta Life Sciences (Alta LS) was established in 2016. Based in Barcelona, the management team is led by the co-founder of Alta Partners Guy Paul Nohra, a leading pioneer VC in life sciences. Alta Partners has funded over 150 companies since 1996. Alta LS specializes in the life sciences sector in Spain and abroad, targeting biotech, genomics, medical devices, diagnostics and digital health. It also acts as a bridge fund, connecting the Spanish life sciences ecosystem to VC experts in Silicon Valley. Investment is available for all stages of development, with focus mainly on seed and Series A funding.

Founded in 2002, Bluesail was initially known as a manufacturer of PVC gloves, with an annual capacity of tens of billions of pairs at its peak. At the end of 2012, it began to expand into more health-related areas.In 2018, it acquired a 93.37% stake in Biosensors International Group that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The two companies were merged and Bluesail began to produce more high-end medical consumables. In 2019, the company and senior executives invested in CH Biomedical to collaborate in the development of innovative medical devices for sale in China and overseas. 

Based in San Francisco, Slow Ventures was founded in 2011 by an early Facebook employee David Morin, who helped to build the Facebook Platform and Facebook Connect. Slow Ventures is no longer known as the “Facebook Alumni Fund”.Today, the VC is a generalist fund, investing in diverse sectors worldwide, ranging from digital health to enterprise solutions. The firm has backed unicorn startups in the US like Postmates, Nextdoor, AngelList and Evernote. A fourth fundraising round has been launched for two new funds totaling $220m: seed funding of $165m and $55m for a follow-up round. Its last funding round closed at $145m in 2016.

Green Monday Ventures is the impact investment arm of Green Monday Group founded by longtime Buddhist David Yeung to produce plant-based meat and operate Hong Kong’s first plant-based concept store.Founded in 2012, the Green Monday movement is a social enterprise aimed at promoting sustainable lifestyle concepts like "green food" to address challenges relating to public health, climate change, food security and animal wellbeing. The Hong Kong-based VC was set up in 2013 to focus on investments in alternative protein companies worldwide.

Founded in 2020 in Boulder, Colorado, Trailhead Capital is a specialist agtech and foodtech investor that focuses on startups in the US, Canada, Australia and Israel. The VC’s regenerative agriculture portfolio includes investments in food ingredients traceability, food supply chains, reducing food waste and soil health environmental management.Recent investments include in the $12m Series A round of Vence, a US-based producer of virtual fencing wearables for livestock management in May 2021. In February 2021, it also participated in the $6m funding round of foodtech HowGood that specializes in rating the sustainability of grocery products.

Sorry, we couldn’t find any matches for“Mental health”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.